Abstract
Minimally invasive and organ-sparing treatments for benign and malignant conditions have improved therapeutic outcomes and quality of life, but unique adverse events are associated with these interventions. The endoscopic treatment of bladder cancer may cause morbidity as a result of disease progression, intraoperative complications, and side effects of therapy. Acute bleeding and ureteral obstruction owing to tumor progression or therapy are reviewed elsewhere in this book (Chapters 13 and 18). Bladder perforation during transurethral resection can lead to tumor dissemination, abdominal distension, and permanent bladder fibrosis. During percutaneous upper urinary tract surgery, injury to the colon, duodenum, lung and great vessels can lead to life-threatening infection, pulmonary compromise, and exsanguination. Systemic infection with bacillus calmette geurin (BCG) during the course of immunotherapy for bladder or upper tract urotehlial cancer, although rare, may lead to fatal sepsis if not promptly recognized and aggressively treated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dick A, Barnes R, Hadley H, Bergman RT, Ninan CA. Complications of transurethral resection of bladder tumors: prevention, recognition and treatment. J Urol 1980; 124(6): 810–811.
Mitchell JP. Transurethral resection for neoplasm of the bladder. In: Endoscopic Operative Urology. (Wright PSG, ed.), Bristol, UK, 1981, pp. 341–363.
Collado A, Chechile GE, Salvador J, Vicente J. Early complications of endoscopic treatment for superficial bladder tumors. J Urol 2000; 164: 1529–1532.
Siegler LJ, Addonidio JC, Fernandez R, Shutte H. Incidence and treatment of bladder perforation following bladder biopsy. Urol 1985; 26(1): 10–11.
Richardson JR Jr, Leadbetter GW Jr. Non-operative treatment of the ruptured bladder. J Urol 1975; 114: 213–216.
Mulkey AP Jr, Witherington R. Conservative management of vesical rupture. Urology 1974; 5: 426–430.
Mydlo JH, Weinstein R, Shah S, et al. Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature. J Urol 1999; 161(4): 1128–1132.
Ohguchi N, Sakaida N, Okamura A, et al. Extravesical tumor implantation caused by perforation during transurethral resection of a bladder tumor: a case report. Int J Urol 1997; 4(5): 516–518.
Ekengren J, Conner P, Lindholm M, Halm RG. Fluid absorption during transurethral bladder surgery. Scand J Urol Nephrol 1995; 29(4): 519–520.
Vansonnenberg E, Mueller PR, Ferrucci JT Jr. Percutaneous drainage of 250 abdominal abscesses and fluid collections. Radiology 1984; 151: 337–341.
Shuster TG, Hollenbeck BK, Faerber GJ, Wolf JS Jr. Complications of ureteroscopy: analysis of predictive factors. J Urol 2001; 166(2): 538–540.
Hollenbeck BK, Shuster TG, Faerber GJ, Wolf JS Jr. Comparison of outcomes of ureteroscopy for ureteral calculi above and below the pelvic brim. Urol 2001; 58(3): 351–356.
Jeromin L, Sosnowski M. Ureteroscopy in the treatment of ureteral stones: over 10 years experience. Eur Urol 1998; 34(4): 344–349.
Harmon WJ, Serson PD, Blute ML, Patterson DE, Segura JW. Ureteroscopy: current practice and long term complications. J Urol 1997; 157(1): 28–32.
Francesca F, Scattoni V, Nava L, et al. Failures and complications of transurethral ureteroscopy in 297 cases: conventional rigid instruments vs small caliber semirigid ureteroscopes. Eur Urol 1995; 28: 112–115.
Kranolowsky EV. Ureteral perforation during ureterorenoscopy: treatment and management. J Urol 1987; 138: 36–38.
Peh OH, Lim PH, Ng FC, et al: Holmium laser lithotripsy in the management of ureteric calculi. Ann Acad Med Singapore 2001; 30(6): 563–567.
Assimos DG, Patterson LC, Taylor CL. Changing incidence and etiology of iatrogenic ureteral injuries. J Urol 1994; 152(6): 2240–2246.
Andersen JR, Ostri P, Jansen JE, Kristensen JK. A retrospective evaluation of 691 ureteroscopies: indications, procedures, success rate and complications. Urol Int 1993; 51(4): 191–197.
Kostakopoulos A, Sofras F, Karayiannis A, Kranidis A, Dimopoulos C. Ureterolithotripsy: report of 1000 cases. Br J Urol 1989; 63(3): 243–244.
Houffman JL. Ureteroscopic injuries to the upper urinary tract. Urol din North Am 1989; 16(2): 249–254.
Weinberg JJ, Ansong K, Smith AD. Complications of ureteroscopy in relation to experience: a reported survey and author experience. J Urol 1987; 137: 384.
Stoller ML, Wolf JS Jr, Hofman R, et al. Ureteroscopy without balloon dilation: an outcome assessment. J Urol 1992; 147: 1238.
Teichman JM, Rao RD, Rogenes VJ, Harris JM. Ureteroscopic management of ureteral calculi: electrohydraulic vs holmium: YAG lithotripsy. J Urol 1997; 158(4): 1357–1361.
Stackl W, Marberger M. Late sequelae of the management of ureteral calculi with the ureterorenoscope. J Urol 1986; 136: 386.
Cheung MC, Lee F, Leung YL, et al. Outpatient ureteroscopy: predictive factors for postoperative events. Urology 2001; 58(6): 914–918.
Chen YT, Chen J, Wong WY, et al. Is ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy? A prospective, randomized controlled trial. J Urol 2002; 167(5): 1977–1980.
Benjamin JC, Donaldson PJ, Hill JT. Ureteric perforation after ureteroscopy. Conservative man agement. Urology 1987; 29(6): 623–624.
Lang EK. Antegrade ureteral stenting for dehiscence, stricture and fistulae. AJR Am J Roentgenol 1984; 143: 795–801.
McDonald JH, Falons JA. Experimental ureteral stricture: ureteral regrowth following ureterotomy with and without intubation. J Urol 1960; 84: 52.
Vansonncnberg E, Mueller PR, Ferrucci JT Jr. Percutaneous drainage of 250 abdominal abscesses and fluid collections. Radiology 1984; 151: 337–341.
Segura JW. Patterson DE. LeRoy AJ, Williams HJ, et al. Percutaneous removal of kidney stones: review of 1000 cases. J Urol 1985; 134: 1077.
O’Donnell A, Scboenberger C, Weiner J, Tsou E. Pulmonary complications of percutaneous nephrostomy and kidney stone extraction. South Med J 1988; 81: 1002.
Fernstrom I, Johannson B. Percutaneous pyelithotomy. A new extraction technique. Scand J Urol Nephrol 1976; 10: 257.
Lee WJ, Smith AD, Cubelli V, Badlani GH, et al. Complications of percutaneous nephrolithotomy. AJR Am J Roentgenol 1987; 148(1): 177–180.
Kondas J, Szentgyorgyi E, Vaczi L, Kiss A. Splenic injury: a rare complication of percutaneous nephrolithotomy. Int Urol Nephrol 1994; 26: 399.
Leroy AJ, Williams HJ, Bender CE, Segura JW, et al. Colon perforation following percutaneous nephrostomy and renal calculus removal. Radiology 1985; 155: 83.
Vallancien G, Capdeville R, Veillon B, Charton M, Brisset JM. Colonic perforation during per cutaneous nephrolithotomy. J Urol 1985; 134: 1185.
Rodrigues Netto N Jr, Lemos GC, Fiuza JL. Colon perforation following percutaneous nephrolithotomy. Urology 1988; 32(3): 223–224.
Ahmed M, Reeve R. Iatrogenic duodeno-cutaneous fistula at percutaneous nephrolithotomy managed conservatively. Br J Urol 1995; 75: 416.
Carson CC, Nesbitt JA. Peritoneal extravasation during percutaneous lithotripsy. J Urol 1985; 134: 725.
Dimberg M, Norlen H, Hoglund N, Allgen LG. Absorption of irrigating fluid during percutaneous transrenal lithotripsy. Scand J Urol Nephrol 1993; 27: 463.
Ratliff TL. The role of the immune response in bacillus Calmette-Guérin for bladder cancer. Eur Urol 1992; 21: 17–21.
Ratliff TL, McCarthy R, Telle WB, et al. Purification of a mycobacterial adhesion for fibronectin. Infect Immunol 1993; 61: 1889–1894.
Kurota K, Brown EJ, Telle WB, et al. Characterization of bacillus Calmette-Guérin by human bladder tumor cells. J Clin Invest 1993; 91: 69–76.
Pattard JJ, Saint F, Velotti F, et al. Immune response following intravesical bacillus Calmette-Guérin instillations in superficial bladder cancer: a review. Urol Res 1998; 26: 155–159.
Lamm DL, Stogdill VD, Stogdill BJ, et al. Complications of bacillus Calmette-Guérin immunotherapy in 1278 patients with bladder cancer. J Urol 1986; 135: 272–274.
Lamm DL. Complications of bacillus Calmette-Guérin immunotherapy. Urol Clin North Am 1992; 19: 565–572.
Lamm DL, van der Meijden PM, Morales A, et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992; 147: 596–600.
Durek C, Rusch-Gerdes S, Jocham D, et al. Interference of modern antibacterials with bacillus Calmette-Guérin viability. J Urol 1999; 162: 1959–1962.
DeHaven JI, Traynellis C, Riggs DR, et al. Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guérin toxicity. J Urol 1992; 147: 738–742.
Durek C, Rusch-Gerdes S, Jocham D, et al. Sensitivity of BCG to modern antibiotics. Eur Urol 1999; 37: 21–25.
Heney NM, Koontz WW, Barton B, et al. Intravesical thiotepa vs mitomycin C in patients with Ta, Tl, and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study. J Urol 1988; 140: 1390–1393.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Ullrich, N.F.E., Ramakumar, S., Dalkin, B.L. (2005). Endoscopic Perforation and Complications of BCG Therapy. In: Wessells, H., McAninch, J.W. (eds) Urological Emergencies. Current Clinical Urology. Humana Press. https://doi.org/10.1385/1-59259-886-2:315
Download citation
DOI: https://doi.org/10.1385/1-59259-886-2:315
Publisher Name: Humana Press
Print ISBN: 978-1-58829-256-8
Online ISBN: 978-1-59259-886-1
eBook Packages: MedicineMedicine (R0)